Blood-based tests to help diagnose pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study uses blood taken from a vein to build and check diagnostic models for pancreatic cancer. It may help doctors identify pancreatic cancer more accurately in people who have a suspected mass on imaging.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have a solid pancreatic mass seen on ultrasound, CT, or MRI (or it is suspected)
- The mass is bigger than 1 centimeter
- You can sign and agree to the study consent form
- You are not pregnant
- Your pancreatic problem is not a cyst-type lesion
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different suction techniques when using a special needle to take tissue samples from a solid pancreas mass during an endoscopic ultrasound. It aims to find the best way to get high-quality samples for diagnosis.
This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.
This trial tests two different ways of using a special needle to take a tissue sample from a pancreatic mass during an endoscopic ultrasound procedure. It aims to see which technique works best for getting a clear diagnosis.
This study looks at a special analysis of your blood (called cfDNA fragmentomics) to help find and tell apart certain early pancreatic tumors. If you’re having surgery for one of the listed solid pancreatic tumors, this trial may use your blood samples to improve diagnosis.
This trial studies whether a blood-based test can help detect pancreatic cancer (or strong signs of it) earlier than usual. The goal is to see how well “liquid biopsy” results match real diagnoses and risk levels.
This trial uses a blood test (called cfDNA) to look for early signs of pancreatic cancer. It compares results from people with pancreatic cancer, precancerous changes, non-cancerous pancreatic conditions, and healthy individuals to improve early detection.
Hear when a new Diagnoses Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.